RedHill Biopharma (RDHL) Receivables (2016 - 2025)
RedHill Biopharma (RDHL) posted quarterly Receivables of $3.1 million for Q4 2025, up 23.47% year-over-year from $2.5 million in Q4 2024, and down 41.4% quarter-over-quarter from $5.4 million in Q2 2025.
RedHill Biopharma (RDHL) Receivables (2016 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has reported Receivables for 10 consecutive years, with $3.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Receivables rose 23.47% year-over-year to $3.1 million; the TTM figure through Dec 2025 stood at $3.1 million (up 23.47% YoY), while the FY2025 annual figure was $3.3 million, up 31.39% from the prior year.
- Receivables declined to $3.1 million in Q4 2025 per RDHL's latest filing, from $5.4 million in the prior quarter.
- Across five years, Receivables topped out at $36.0 million in Q3 2022 and bottomed at $974000.0 in Q2 2024.
- Historically, Receivables has averaged $18.2 million across 5 years, with a median of $23.3 million in 2021.
- Annual changes were most pronounced in 2021 — Receivables surged 1257.37% — and 2023, when it plunged 92.49%.
- RedHill Biopharma's Receivables stood at $31.7 million in 2021, then grew by 8.98% to $34.5 million in 2022, then slumped by 92.49% to $2.6 million in 2023, then retreated by 2.01% to $2.5 million in 2024, then climbed by 23.47% to $3.1 million in 2025.
- Business Quant data shows RDHL's Receivables at $3.1 million in Q4 2025, $5.4 million in Q2 2025, and $2.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 1.08 Bn |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.14 Mn |
| Jun 30, 2025 | 5.35 Mn |
| Dec 31, 2024 | 2.54 Mn |
| Jun 30, 2024 | 974,000.00 |
| Dec 31, 2023 | 2.59 Mn |
| Jun 30, 2023 | 4.24 Mn |
| Mar 31, 2023 | 6.85 Mn |
| Dec 31, 2022 | 34.52 Mn |
| Sep 30, 2022 | 36.01 Mn |
| Jun 30, 2022 | 35.63 Mn |
| Mar 31, 2022 | 25.93 Mn |
| Dec 31, 2021 | 31.68 Mn |
| Sep 30, 2021 | 30.04 Mn |
| Jun 30, 2021 | 30.10 Mn |
| Mar 31, 2021 | 23.31 Mn |
| Dec 31, 2020 | 28.66 Mn |
| Sep 30, 2020 | 12.42 Mn |
| Jun 30, 2020 | 18.57 Mn |
| Mar 31, 2020 | 1.72 Mn |
| Dec 31, 2019 | 1.22 Mn |